Cargando…

Cartilage degradation is fully reversible in the presence of aggrecanase but not matrix metalloproteinase activity

INTRODUCTION: Physiological and pathophysiological cartilage turnover may coexist in articular cartilage. The distinct enzymatic processes leading to irreversible cartilage damage, compared with those needed for continuous self-repair and regeneration, remain to be identified. We investigated the ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karsdal, Morten A, Madsen, Suzi H, Christiansen, Claus, Henriksen, Kim, Fosang, Amanda J, Sondergaard, Bodil C
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2483454/ https://www.ncbi.nlm.nih.gov/pubmed/18513402 http://dx.doi.org/10.1186/ar2434

Ejemplares similares

Aggrecanases and cartilage matrix degradation
por: Nagase, Hideaki, et al.
Publicado: (2003)

Suppression of MMP activity in bovine cartilage explants cultures has little if any effect on the release of aggrecanase-derived aggrecan fragments
por: Wang, Bijue, et al.
Publicado: (2009)

Coculture of bovine cartilage with synovium and fibrous joint capsule increases aggrecanase and matrix metalloproteinase activity
por: Swärd, Per, et al.
Publicado: (2017)

ADAMTS-9 in Mouse Cartilage Has Aggrecanase Activity That Is Distinct from ADAMTS-4 and ADAMTS-5
por: Rogerson, Fraser M., et al.
Publicado: (2019)

Matrix metalloproteinase-degraded type I collagen is associated with APOE/TOMM40 variants and preclinical dementia
por: Tang, Man-Hung Eric, et al.
Publicado: (2020)

Collagenases and aggrecanases: understanding the role of non-catalytic domains in cartilage matrix breakdown
por: Nagase, H, et al.
Publicado: (2005)

High molecular weight hyaluronan protects cartilage from degradation by inhibiting aggrecanase expression
por: Ohtsuki, Takashi, et al.
Publicado: (2018)

Rat tail static compression model mimics extracellular matrix metabolic imbalances of matrix metalloproteinases, aggrecanases, and tissue inhibitors of metalloproteinases in intervertebral disc degeneration
por: Yurube, Takashi, et al.
Publicado: (2012)

Aggrecanase-selective tissue inhibitor of metalloproteinase-3 (TIMP3) protects articular cartilage in a surgical mouse model of osteoarthritis
por: Nakamura, Hiroyuki, et al.
Publicado: (2020)

Metalloelastase-12 is involved in the temporomandibular joint inflammatory response as well as cartilage degradation by aggrecanases in STR/Ort mice
por: Yamashita-Futani, Yoko, et al.
Publicado: (2021)

The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis
por: Bondeson, Jan, et al.
Publicado: (2006)

Is radiographic progression in radiographic axial spondyloarthritis related to matrix metalloproteinase degradation of extracellular matrix?
por: Siebuhr, Anne Sofie, et al.
Publicado: (2018)

Investigation of the direct effects of salmon calcitonin on human osteoarthritic chondrocytes
por: Sondergaard, Bodil-Cecilie, et al.
Publicado: (2010)

Characterization of an Ex vivo Femoral Head Model Assessed by Markers of Bone and Cartilage Turnover
por: Madsen, Suzi Hoegh, et al.
Publicado: (2011)

Matrix Metalloproteinase-dependent turnover of cartilage, synovial membrane, and connective tissue is elevated in rats with collagen induced arthritis
por: Siebuhr, Anne Sofie, et al.
Publicado: (2012)

Development of a highly sensitive chemiluminescence immunoassay for quantification of aggrecanase-generated ARGS aggrecan fragments in serum
por: He, Yi, et al.
Publicado: (2021)

CXCL12/CXCR4 Axis Regulates Aggrecanase Activation and Cartilage Degradation in a Post-Traumatic Osteoarthritis Rat Model
por: Lu, Weiwei, et al.
Publicado: (2016)

Osteoclasts degrade bone and cartilage knee joint compartments through different resorption processes
por: Löfvall, Henrik, et al.
Publicado: (2018)

Current and emerging therapeutic strategies for preventing inflammation and aggrecanase-mediated cartilage destruction in arthritis
por: Dancevic, Carolyn M, et al.
Publicado: (2014)

Roles of metalloproteinase-3 and aggrecanase 1 and 2 in aggrecan cleavage during human meniscus degeneration
por: Ishihara, Gintaro, et al.
Publicado: (2009)

Matrix Metalloproteinase Mediated Type I Collagen Degradation is an Independent Predictor of Increased Risk of Acute Myocardial Infarction in Postmenopausal Women
por: Bertelsen, Ditte Marie, et al.
Publicado: (2018)

Matrix Metalloproteinase Mediated Type I Collagen Degradation — An Independent Risk Factor for Mortality in Women
por: Dragsbæk, K., et al.
Publicado: (2015)

Two novel blood-based biomarker candidates measuring degradation of tau are associated with dementia: A prospective study
por: Neergaard, Jesper Skov, et al.
Publicado: (2018)

Matrix metalloproteinase-3 inhibitor retards treadmill running-induced cartilage degradation in rats
por: Ni, Guo-Xin, et al.
Publicado: (2011)

The presence of extracellular matrix degrading metalloproteinases during fetal development of the intervertebral disc
por: Rutges, J. P. H. J., et al.
Publicado: (2010)

Does increased local bone resorption secondary to breast and prostate cancer result in increased cartilage degradation?
por: Leeming, Diana J, et al.
Publicado: (2008)

Phosphodiesterase inhibition mediates matrix metalloproteinase activity and the level of collagen degradation fragments in a liver fibrosis ex vivo rat model
por: Veidal, Sanne Skovgård, et al.
Publicado: (2012)

Circulating Protein Fragments of Cartilage and Connective Tissue Degradation Are Diagnostic and Prognostic Markers of Rheumatoid Arthritis and Ankylosing Spondylitis
por: Bay-Jensen, Anne C., et al.
Publicado: (2013)

Tibolone inhibits bone resorption without secondary positive effects on cartilage degradation
por: Karsdal, MA, et al.
Publicado: (2008)

Extracellular Matrix Proteomics Reveals Interplay of Aggrecan and Aggrecanases in Vascular Remodeling of Stented Coronary Arteries
por: Suna, Gonca, et al.
Publicado: (2018)

Characterization of Selective Exosite-Binding Inhibitors of Matrix Metalloproteinase 13 That Prevent Articular Cartilage Degradation in Vitro
por: Spicer, Timothy P., et al.
Publicado: (2014)

Biglycan fragmentation in pathologies associated with extracellular matrix remodeling by matrix metalloproteinases
por: Genovese, Federica, et al.
Publicado: (2013)

Biochemical markers identify influences on bone and cartilage degradation in osteoarthritis - the effect of sex, Kellgren-Lawrence (KL) score, Body Mass Index (BMI), oral salmon calcitonin (sCT) treatment and diurnal variation
por: Karsdal, MA, et al.
Publicado: (2010)

Desumoylation of aggrecan and collagen II facilitates degradation via aggrecanases in IL-1β-mediated osteoarthritis
por: Zhu, Bing, et al.
Publicado: (2019)

Measurement of matrix metalloproteinase 9-mediated Collagen type III degradation fragment as a marker of skin fibrosis
por: Vassiliadis, Efstathios, et al.
Publicado: (2011)

Patients with rheumatoid arthritis have an altered circulatory aggrecan profile
por: Rousseau, Jean C, et al.
Publicado: (2008)

Mechanisms of cartilage matrix turnover: synergistic interactions of proinflammatory cytokines with oncostatin M in upregulating matrix metalloproteinases and ADAMTS metalloproteinases
por: Cawston, TE, et al.
Publicado: (2005)

Clinical evaluation of a matrix metalloproteinase-12 cleaved fragment of titin as a cardiovascular serological biomarker
por: Vassiliadis, Efstathios, et al.
Publicado: (2012)

GPDPLQ(1237)—A Type II Collagen Neo-Epitope Biomarker of Osteoclast- and Inflammation-Derived Cartilage Degradation in vitro
por: Löfvall, Henrik, et al.
Publicado: (2019)

Cartilage destruction by matrix degradation products
por: Yasuda, Tadashi
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_s542nhf2nrolpukmv3ruk85gre